HealthCare Global Enterprises Limited (NSE:HCG)
India · Delayed Price · Currency is INR 570.85
+5.30 (0.94%)
Nov 12, 2026, 3:29 PM IST
NSE:HCG Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 27,123 | 25,454 | 22,229 | 19,121 | 16,944 | 13,978 |
Revenue Growth | 12.84% | 14.51% | 16.25% | 12.85% | 21.22% | 37.92% |
Gross Profit Gross Profit Growth | 14,281 | 13,709 | 11,910 | 10,475 | 9,198 | 7,521 |
Operating Income Operating Income Growth | 2,348 | 2,278 | 1,752 | 1,555 | 1,355 | 795.46 |
Net Income Net Income Growth | 112.95 | 137.55 | 444.1 | 481.55 | 293.49 | 537.33 |
Earnings Per Share EPS Growth | 0.77 | 0.96 | 3.12 | 3.43 | 2.10 | 3.97 |
EPS Growth | -69.26% | -69.23% | -9.04% | 63.33% | -47.10% | - |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 24,644 | 21,748 | 18,898 | 16,815 | 13,948 |
outside India outside India Growth | 740.21 | 433.14 | 180.3 | 99.01 | - |
Total Total Growth | 25,384 | 22,181 | 19,079 | 16,914 | 13,948 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,274 | 5,477 | 3,477 | 3,031 | 1,966 | 2,042 |
Total Debt Total Debt Growth | 16,093 | 17,354 | 18,372 | 12,744 | 9,012 | 9,147 |
Net Cash (Debt) Net Cash Growth | -14,819 | -11,877 | -14,895 | -9,713 | -7,046 | -7,105 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -101.09 | -83.19 | -104.62 | -69.18 | -50.43 | -52.56 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,941 | 3,471 | 3,171 | 2,846 | 2,516 | 2,201 |
Capital Expenditures CapEx Growth | -2,643 | -2,921 | -2,089 | -1,857 | -1,332 | -712.32 |
Free Cash Flow Free Cash Flow Growth | 298.58 | 549.88 | 1,082 | 988.99 | 1,184 | 1,489 |
Free Cash Flow Growth | -79.92% | -49.20% | 9.45% | -16.44% | -20.51% | 74.97% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 52.65% | 53.86% | 53.58% | 54.78% | 54.28% | 53.80% |
Operating Margin | 8.66% | 8.95% | 7.88% | 8.13% | 8.00% | 5.69% |
Pretax Margin | 1.43% | 1.06% | 2.56% | 3.54% | 2.65% | 6.28% |
Profit Margin | 0.42% | 0.54% | 2.00% | 2.52% | 1.73% | 3.84% |
FCF Margin | 1.10% | 2.16% | 4.87% | 5.17% | 6.98% | 10.65% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 744.13 | 570.07 | 170.10 | 97.72 | 124.40 | 69.83 |
Forward PE | 43.07 | 65.80 | 79.65 | 62.39 | 47.99 | 125.83 |
P/FCF Ratio | 285.45 | 142.60 | 69.79 | 47.58 | 30.85 | 25.20 |
PS Ratio | 3.14 | 3.08 | 3.40 | 2.46 | 2.15 | 2.68 |